A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia.
about
Vascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and FerritinGamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease RiskNonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment optionsPrevention of hepatocellular carcinoma: Focusing on antioxidant therapyDysregulation of iron and copper homeostasis in nonalcoholic fatty liverIron and non-alcoholic fatty liver diseaseEpidemiological associations between iron and cardiovascular disease and diabetes.Hepatic iron in African Americans who underwent liver biopsy.Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver DiseaseThe Role of Iron and Iron Overload in Chronic Liver Disease.Clinical applications of therapeutic phlebotomyGenetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.Effects of iron supplementation in mice with hypoferremia induced by obesity.Outcome of phlebotomy for treating nonalcoholic fatty liver disease: A systematic review and meta-analysis.Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitisHyperferritinemia in patients with nonalcoholic fatty liver disease.Systematic review and meta-analysis to determine the impact of iron depletion in dysmetabolic iron overload syndrome and non-alcoholic fatty liver disease.The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candiMetabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients.Dietary Iron Supplementation Alters Hepatic Inflammation in a Rat Model of Nonalcoholic Steatohepatitis.Hepcidin resistance in dysmetabolic iron overload.Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker.EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis
P2860
Q26750865-83A62651-05A6-4ED5-BEA5-24C16517BE60Q26778935-53C820E6-F53A-46FA-B603-20E0FB3B4DA6Q26796448-E29BB7A0-640C-4C5F-A7A2-22212891E9D6Q26853520-8A8B4347-64B8-4453-BBDB-AC5868B58449Q26996539-BEBFBCAD-560E-4B3F-AD84-43401CA3BB0DQ28070303-C3C5AAF9-4C5B-434A-B34E-271AE68ACD9EQ33659310-88D8C81E-D863-4DA0-B5FB-FE3E5D37CE1AQ34796902-6744A9AF-3663-4681-BEC5-88B6EB6E30CCQ36138443-CEAB7F35-2BF3-4FA4-AE77-319BAAEEF679Q37042599-231DD246-F12B-4CAC-9AFD-25C4B64A8479Q37118972-3CDFF02A-9D8A-4133-9130-E1B3A32BD2D2Q37146192-1C7F7A9C-91F6-4742-AB33-AF31ED5C7267Q37403758-A5807355-554F-4B4E-B154-5B23439FC627Q37532228-25BA011B-5C30-4932-A90B-FC520BF69B65Q38699261-E7374ECD-CDDA-4C8E-BC61-D2E63A80230BQ38794485-B3D7FA89-0628-4131-8808-6863E745D19DQ39359052-26E32ECA-FB8D-48FA-A4E9-54DEACC375D8Q40088550-DE46B47E-7CC1-45EA-BC15-E6FBA1D321BDQ48329465-0C94AC84-53F0-416F-833B-6B1F5896B24EQ50142613-9D54EEF7-43B8-42AB-84A6-55C58D4251A4Q53141858-CE7A7FE6-4351-4ABD-AB84-2A8AD252E39EQ55438778-1D7F44D9-0C8C-408E-A0CD-5C0418C88091Q55497819-04A12839-0E1E-4C23-ABE4-76F1BD73284BQ57192818-EBB9F043-847C-4D7D-9829-179428B1A898
P2860
A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A randomized trial of iron dep ...... disease and hyperferritinemia.
@en
A randomized trial of iron dep ...... disease and hyperferritinemia.
@nl
type
label
A randomized trial of iron dep ...... disease and hyperferritinemia.
@en
A randomized trial of iron dep ...... disease and hyperferritinemia.
@nl
prefLabel
A randomized trial of iron dep ...... disease and hyperferritinemia.
@en
A randomized trial of iron dep ...... disease and hyperferritinemia.
@nl
P2093
P2860
P50
P356
P1476
A randomized trial of iron dep ...... disease and hyperferritinemia
@en
P2093
Edoardo Alessandro Pulixi
Erika Fatta
Marco Maggioni
Paola Dongiovanni
Serena Rovida
Silvia Fargion
P2860
P304
P356
10.3748/WJG.V20.I11.3002
P407
P577
2014-03-01T00:00:00Z